Key facts
- MicroPort Orthopedics (China)’s last known valuation is $552.6M (May 2020).
- It has raised $82.0M; the latest was Secondary Transaction - Private in Nov 2025.
- Notable investors include China Life Private Equity, Assured Asset Management, CQY Capital, E Fund Asset Management, ORIX Asia Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for MicroPort Orthopedics (China)
- ·The full record, as it builds
Funding rounds
No funding rounds for MicroPort Orthopedics (China) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MicroPort Orthopedics (China)
Developer of minimally invasive orthopedic equipment for bone disease patients. The company specializes in the development, production and sale of innovative orthopedic joint reconstruction products and equipment, providing a variety of integrated orthopedic medical solutions for patients with bone diseases.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2012
- Website
- microport.com.cn/
- Ownership
- Privately Held (backing)
MicroPort Orthopedics (China) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MicroPort Orthopedics (China) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MicroPort Orthopedics (China) in its N-PORT filings yet. We sweep new filings monthly.